Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v10-EN | Version v8-EN | |
---|---|---|
Language | English | English |
Date Updated | 2023-12-08 | 2022-10-04 |
Drug Identification Number | 02329468 | 02329468 |
Brand name | HIGH PURITY INDIUM CHLORIDE IN 111 STERILE SOLUTION | HIGH PURITY INDIUM CHLORIDE IN 111 STERILE SOLUTION |
Common or Proper name | High Purity Indium Chloride (In111) sterile solution | High Purity Indium Chloride (In111) sterile solution |
Company Name | CURIUM CANADA INC | CURIUM CANADA INC |
Ingredients | INDIUM IN 111 CHLORIDE | INDIUM IN 111 CHLORIDE |
Strength(s) | 10MCI | 10MCI |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
Packaging size | 10ml vial | 10ml vial |
ATC code | UNASS | UNASS |
ATC description | ||
Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated start date | ||
Actual start date | 2022-02-22 | 2022-02-22 |
Estimated end date | Unknown | Unknown |
Actual end date | ||
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | in order to accommodate preventative maintenance work on cyclotrons, we are suspending production of this product until further notice. We will provide future updates as we determine the expected timeline to resume production. | in order to accommodate preventative maintenance work on cyclotrons, we are suspending production of this product until further notice. We will provide future updates as we determine the expected timeline to resume production. |
Health Canada comments |